Skip to main content

Table 2 Antimicrobial susceptibility profiles of the most common gram-positive bacteria

From: The need to improve antimicrobial susceptibility testing capacity in Ugandan health facilities: insights from a surveillance primer

Antimicrobials

S. aureus

S. pneumoniae

S. pyogenes

Enterococcus spp

S. viridians

R

n (%)

S

n (%)

R

n (%)

S

n (%)

R

n (%)

S

n (%)

R

n (%)

S

n (%)

R

n (%)

S

n (%)

AMP

46 (86.8)

7 (13.2)

1 (50)

1 (50)

1 (100)

0 (0)

3 (50)

3 (50)

1 (100)

0 (0)

A

1 (100)

0 (0)

c

c

a

a

c

c

a

a

FOX

17 (32.7)

33 (63.5)

c

c

c

c

c

c

c

c

SXT

39 (66.1)

19 (32.2)

1 (100)

0 (0)

c

c

c

c

c

c

CIP

21 (52.5)

18 (45)

c

c

c

c

2 (100)

0 (0)

c

c

CN

51 (52.6)

46 (46.9)

c

c

c

c

c

c

1 (100)

0 (0)

P

a

a

a

a

a

a

a

a

a

a

VAN

13 (13.7)

82 (86.3)

0 (0)

1 (100)

0 (0)

1 (100)

1 (33.3)

2 (66.7)

0 (0)

1 (100)

AMC

c

c

1 (50)

1 (50)

c

c

c

c

c

c

C

28 (42.4)

38 (57.6)

1 (100)

0 (0)

a

a

a

a

a

a

DA

9 (19.1)

38 (80.9)

a

a

a

a

c

c

a

a

E

c

c

a

a

1 (100)

0 (0)

1 (50)

1 (50)

1 (100)

0 (0)

N

1 (16.7)

5 (83.3)

c

c

c

c

1 (100)

0 (0)

c

c

CTX

c

c

a

a

a

a

c

c

a

a

IMP

c

c

a

a

a

a

c

c

a

a

CRO

c

c

a

a

a

a

c

c

a

a

TE

12 (80)

2 (13.3)

a

a

a

a

0 (0)

3 (100)

a

a

CXM

c

c

a

a

a

a

c

c

c

c

RIF

3 (16.7)

15 (83.3)

0 (0)

1 (100)

c

c

1 (50)

1 (50)

c

c

AZT

c

c

c

c

c

c

c

c

c

c

  1. R—Resistant, S—Sensitive, %—bacteria screened against a particular antimicrobial, a and c—antimicrobial not screened against the bacteria (due to c—CLSI guidelines or a—total absence or unavailability in the lab), AMP—Ampicillin, A—Azithromycin, FOX—Cefoxitin, CN—Gentamicin, IPM—Imipenem, CIP—Ciprofloxacin, CTX—Cefotaxime, AZT—Aztreonam, AMC—Amoxicillin-clavulanic acid, N—Nitrofurantoin, SXT—Cotrimoxazole, CXM—Cefuroxime, CRO—Ceftriaxone, C—Chloramphenicol, P—Penicillin, VAN—Vancomycin, DA—Clindamycin, E—Erythromycin, TE—Tetracycline, RIF—Rifampicin